Sympathoadrenal control by paraventricular hypothalamic beta-endorphin in hypertension

Area of Science:

• Neuroscience
• Cardiovascular Physiology
• Endocrinology

Background:

• The paraventricular hypothalamus (PVH) is crucial for autonomic nerve regulation.
• Beta-endorphin nerve terminals are present in the PVH, suggesting a role in its function.

Purpose of the Study:

• To investigate the effects of beta-endorphin microinjected into the PVH on cardiovascular and sympathoadrenal activity in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats.
• To explore the influence of the PVH beta-endorphin system on hypertension.

Main Methods:

• Microinjection of beta-endorphin into the PVH of conscious, unrestrained SHR and WKY rats.
• Measurement of blood pressure, heart rate, plasma catecholamines (norepinephrine, epinephrine), and glucose concentrations.
• Pharmacological interventions including ganglionic blockade with pentolinium and naltrexone pretreatment.

Main Results:

• Beta-endorphin injection into the PVH increased blood pressure and heart rate in both rat strains, with greater effects in SHR.
• Plasma epinephrine and glucose levels increased significantly in SHR, while norepinephrine increased only in SHR.
• Naltrexone pretreatment blocked these responses in SHR, indicating opioid receptor involvement.

Conclusions:

• Conscious SHR exhibit heightened cardiovascular and sympathoadrenal responses to PVH beta-endorphin compared to WKY rats.
• The PVH beta-endorphin system may play a role in modulating the development or maintenance of hypertension in SHR.